1. Dihydroartemisinin as a Sensitizing Agent in Cancer Therapies
   Qingrong Li et al, 2021, OncoTargets and Therapy CrossRef
2. Dihydroartemisinin ameliorates the liver steatosis in metabolic associated fatty liver disease mice by attenuating the inflammation and oxidative stress and promoting autophagy
   Yiyi Hu et al, 2023, Acta Cirúrgica Brasileira CrossRef
3. A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma
   Bo Chen et al, 2022, Computers in Biology and Medicine CrossRef
4. Dihydroartemisinin suppresses glioma growth by repressing ERRα-mediated mitochondrial biogenesis
   Wenxin Zhang et al, 2024, Molecular and Cellular Biochemistry CrossRef
5. Dihydroartemisinin regulates the immune system by promotion of CD8+ T lymphocytes and suppression of B cell responses
   Ting Zhang et al, 2020, Science China Life Sciences CrossRef
6. Development of nanoscale drug delivery systems of dihydroartemisinin for cancer therapy: A review
   Ka Hong Wong et al, 2022, Asian Journal of Pharmaceutical Sciences CrossRef
7. Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
   Renxin Yi et al, 2020, Bioscience Reports CrossRef
8. Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways
   Lianli Ni et al, 2024, Neoplasia CrossRef
9. Target prediction and potential application of dihydroartemisinin on hepatocarcinoma treatment
   Wenjia Guo et al, 2024, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
10. Dihydroartemisinin Modulates Apoptosis and Autophagy in Multiple Myeloma through the P38/MAPK and Wnt/β-Catenin Signaling Pathways
    Xiuhua Wu et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
11. Dihydroartemisinin: A Potential Drug for the Treatment of Malignancies and Inflammatory Diseases
    Ran Yu et al, 2021, Frontiers in Oncology CrossRef
12. The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?
    Mariana Medeiros et al, 2021, Cellular and Molecular Life Sciences CrossRef
13. Natural Compounds in Glioma Therapy
    Vasiliki Zoi et al, 2023, CrossRef
14. Dihydroartemisinin Attenuates Pulmonary Hypertension Through Inhibition of Pulmonary Vascular Remodeling in Rats
    Ming Tang et al, 2020, Journal of Cardiovascular Pharmacology CrossRef
15. Dihydroartemisinin inhibits EMT of glioma via gene BASP1 in extrachromosomal DNA
    Zhongyou Que et al, 2023, Biochemical and Biophysical Research Communications CrossRef